0001654954-22-016711.txt : 20221220 0001654954-22-016711.hdr.sgml : 20221220 20221220113713 ACCESSION NUMBER: 0001654954-22-016711 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20221215 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20221220 DATE AS OF CHANGE: 20221220 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Onfolio Holdings, Inc CENTRAL INDEX KEY: 0001825452 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-41466 FILM NUMBER: 221473542 BUSINESS ADDRESS: STREET 1: 1007 NORTH ORANGE STREET 4TH FLOOR CITY: WILMINGTON STATE: DE ZIP: 19801 BUSINESS PHONE: (682) 990-6920 MAIL ADDRESS: STREET 1: 1007 NORTH ORANGE STREET 4TH FLOOR CITY: WILMINGTON STATE: DE ZIP: 19801 FORMER COMPANY: FORMER CONFORMED NAME: Onfolio Holdings Inc DATE OF NAME CHANGE: 20200923 FORMER COMPANY: FORMER CONFORMED NAME: Onfolio Holdings, Inc. DATE OF NAME CHANGE: 20200921 8-K 1 onfolio_8k.htm FORM 8-K wordproof.doc

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): December 15, 2022

 

ONFOLIO HOLDINGS INC.

(Exact name of registrant as specified in its charter)

 

Delaware

 

001-41466

 

37-1978697

(State or other jurisdiction of

 

(Commission

 

(I.R.S. Employer

incorporation or organization)

 

File Number)

 

Identification Number)

 

1007 North Orange Street, 4th Floor, Wilmington, Delaware

 

19801

(Address of principal executive offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code (682) 990-6920

 

_______________________________________________

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

     Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, $0.001 par value per share

ONFO

Nasdaq Capital Market

Warrants To Purchase Common Stock

ONFOW

Nasdaq Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company  

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

 

On December 15, 2022, Jack W. Hawkins tendered his resignation as Chief Financial Officer of Onfolio Holdings Inc. (the “Company”), effective December 31, 2022. Mr. Hawkins’ departure was not the result of any disagreement with the Company nor any issue related to the Company’s financial statements or accounting practices. Rob te Braake, the Company’s financial advisor will serve as the Company’s Interim Chief Financial Officer and will continue to operate in that capacity until a new Chief Financial Officer has been appointed. Mr. Hawkins is expected to remain with the Company until at least March 2023 in a non-executive role to assist Mr. te Braake with his transition into the Interim Chief Financial Officer position.

 

On December 15, 2022, Rob te Braake, the Company’s financial advisor, was appointed by the Company’s Board of Directors to serve as the Company’s Interim Chief Financial Officer effective January 1, 2023 until the Company appoints a new Chief Financial Officer. As the Company’s Interim Chief Financial Officer, Mr. te Braake will be responsible for (i) analyzing budget and finances (alongside the President); (ii) creating and presenting financial and tax strategy recommendations to the executive team; (iii) overseeing cash flow, cash management, working capital, and company audits; (iv) preparing financial statements and reports, including SEC filings; (v) ensuring legal compliance on all financial functions; (vi) other duties as may be prescribed by the Company’s Chief Executive Officer from time to time.

 

There are no arrangements or understandings between Mr. te Braake and any other persons pursuant to which he was appointed as the Company’s Interim Chief Financial Officer. There is no family relationship between Mr. te Braake and any director, executive officer, or person nominated or chosen by the Company to become a director or executive officer of the Company. The Company has not entered into any transactions with Mr. te Braake that would require disclosure pursuant to Item 404(a) of Regulation S-K under the Securities Exchange Act of 1934.

 

Mr. te Braake, age 39 has served as a financial advisor to the Company since 2020 where he provided all bookkeeping services to all of Company’s legal entities, as well performing finance/accounting related projects, through Calixtus Ltd, a business advisory firm that he owns. Since March 2017, Mr. te Braake served as a Director of Calixtus Ltd. Mr. te Braake has 5+ years of experience working as advisor, fractional CFO and similar roles to companies in similar industries as the Company and 10+ years of experience on the intersection of finance and international entrepreneurship.

 

Mr. te Braake entered into a written employee agreement with the Company whereby Mr. te Braake will receive as compensation, among other things, a base salary of $168,000 per year. Additionally, Mr. te Braake will be entitled to participate in any Company executive bonus plan in effect during his employment or association with the Company. Any payout related to any bonus opportunity will be solely at the discretion of the Company’s Board of Directors and may be modified from time to time by the Board of Directors in its sole discretion. A copy of Mr. te Braake’s employee agreement is attached as Exhibit 10.1 to this Form 8-K and is incorporated herein by reference.

 

Item 9.01 Financial Statements and Exhibits

 

(d)  Exhibits.

 

Exhibit No.

 

Description

10.1

 

Employee Agreement – Rob te Braake

104

 

Cover Page Interactive Data File (formatted as Inline XBRL)

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

ONFOLIO HOLDINGS INC.

 

 

 

 

 

Date: December 20, 2022

By:

/s/ Dominic Wells

 

 

 

Dominic Wells,

 

 

 

Chief Executive Officer

 

 

 

 

EX-10.1 2 onfolio_ex101.htm EX-10.1 onfolio_ex101.htm

EXHIBIT 10.1

 

EMPLOYEE AGREEMENT

 

This Agreement (the “Agreement”) is made and entered into as January 01 2023 by Onfolio Holdings Inc., a Delaware corporation (the “Company”), including its subsidiaries, affiliates, assignees, and successors, each of whom are expressly authorized to enforce this Agreement, and who are referenced herein as “the Company” and Robertus te Braake, referenced herein as “you” or “your” or “Employee”.

 

1.

CONSIDERATION. You agree that this Agreement is entered into in consideration of the mutual promises contained in this Agreement and other good and valuable consideration, and in further consideration of your employment or association with the Company. Your employment or association with the Company is at-will and may be terminated at any time at the election of either party. This Agreement does not guarantee your employment by or association with the Company for any definite period of time.

 

 

2.

REPRESENTATIONS AND WARRANTIES. You represent and warrant to the Company that the following statements are true and correct and shall remain true and correct at all times during your employment or association with the Company:

 

 

a.

All statements and representations contained in your application for employment or association are true and correct; and

 

 

 

 

b.

This Agreement constitutes a legal, valid, and binding agreement and obligation enforceable against you in accordance with its terms.

 

 

 

3.

POSITION AND DUTIES. The Company agrees to employ you to act as its Interim Chief Financial Officer effective as of January 01, 2023. You shall be responsible for (i) analyzing budget and finances (alongside the President); (ii) creating and presenting financial and tax strategy recommendations to the executive team; (iii) overseeing cash flow, cash management, working capital, and company audits; (iv) preparing financial statements and reports, including SEC filings; (v) ensuring legal compliance on all financial functions; (vi) other duties as may be prescribed by the Company’s Chief Executive Officer from time to time. You agree that you will serve the Company faithfully and to the best of your ability during the term of employment, under the direction of the Chief Executive Officer of the Company.

 

 

4.

PLACE OF EMPLOYMENT. You shall perform your duties under this Employee Agreement at home, or the Company’s then-current headquarters office.

 

 

5.

COMPENSATION OF EMPLOYEE. For all services rendered, you shall initially receive compensation as follows:

 

 

a.

Base Salary: The Company agrees to pay you at a rate of $168,000 per year, which may be increased from time to time by the Board’s Compensation Committee, except pursuant to across-the-board salary reductions affecting all other senior executives of the Employer, may not be decreased. The Base Salary will be payable on a semi-monthly basis, or on whatever basis Company may adopt in the future, in accordance with the Company’s standard payroll practices.

 

 
Page 1

 

 

 

b.

Bonus: You will be eligible for participation in any Company executive bonus plan in effect during your employment or association with the Company. Any payout related to your bonus opportunity will be solely at the discretion of the Board and may be modified from time to time by the Board in their sole discretion.

 

 

 

 

c.

Withholdings: All amounts due from the Company to the Employee hereunder shall be paid to the Employee net of all taxes and other amounts which the Company is required to withhold by law.

 

6.

REIMBURSEMENT FOR BUSINESS EXPENSES. Subject to the approval of the Company, the Company shall promptly pay or reimburse you for all reasonable business expenses incurred in performing your duties and obligations under this Employee Agreement, but only if you properly account for expenses in accordance with the Company’s policies.

 

 

7.

PAID TIME OFF AND BENEFITS. You shall be entitled to the same benefits, paid time off and Company holidays offered by the Company to its other employees. Nothing in this Employee Agreement shall prohibit the Company from modifying or terminating any of its employee benefit plans in a manner that does not discriminate between you and other Company employees.

 

 

8.

TERMINATION OF EMPLOYMENT. Your employment hereunder shall automatically terminate upon (i) your death; (ii) your voluntarily leaving the employ of the Company; (iii) at the Company’s sole discretion, for any reason, with or without cause.

 

 

 

a.

Payment on Termination: In the event your employment under this agreement is terminated for any reason, Company shall promptly pay you any amounts due to you under this agreement, including any salary accrued through the date of termination, and reimbursement for business related expenses during the period of your employment, providing that such expenses are submitted in accordance with Company policies. In the event that you leave the Company’s employment for Good Reason or if the Company terminates your employment without Cause, you shall be entitled to receive severance in an amount equal to one day of base salary for every completed work day of employment with the Company, up to a maximum of three (3) months of base salary.

 

 

 

 

b.

For Purposes Hereof, “Good Reason” means (i) a reduction in your Annual Base Salary of more than five (5) percent, other than pursuant to an across-the-board reduction in accordance with Section 5, (ii) a material diminution in your duties or responsibilities inconsistent with your position, or (iii) a change in your principal office to a location more than thirty-five (35) miles from your principal residence as of the date of relocation, without your prior written consent; provided that you must deliver written notice of your resignation to the Company within 30 days of your actual knowledge of any such event, the Company must be provided at least 30 days during which it may remedy the condition and you must terminate your employment within twelve (12) months of the initial occurrence of Good Reason in order for such resignation to be with Good Reason for any purpose hereunder.

 

 

 

 
Page 2

 

 

 

c.

For Purposes Hereof, “Cause” means (i) the conviction or plea of guilty or no contest for or indictment on a felony or a crime involving moral turpitude or the commission of any other act or omission involving misappropriation, embezzlement or fraud, which involves a material matter with respect to the Company or any of their customers or suppliers; (ii) substantial and repeated failure to perform duties of the office you hold as reasonably directed by the Board after notice from the Board and a reasonable opportunity to respond to such notice; (iii) gross negligence or willful misconduct with respect to the Company that is or could reasonably be expected to be harmful to the Company in any material respect after notice from the Board and a reasonable opportunity to respond to such notice.

 

9.

BEST EFFORTS AND OUTSIDE ACTIVITIES. You shall devote all of the necessary business time, attention, and energies, as well as your best talents and abilities to the business of the Company in accordance with the Company’s instructions and directions. You may engage to a limited extent in other business activities unrelated to the Company so long as such activities do not create a conflict of interest or otherwise interfere with the performance of your duties and the terms and conditions of this Agreement.

 

 

10.

RECORDS OWNERSHIP. You acknowledge, understand, and agree that all files, records and documents, whether in hard copy, electronic or any other form, generated or received by the Company or its employees, or concerning the Company or its business, belong to and constitute the property of Company and that Company is the records owner of all such files, records and documents. Therefore, upon your separation from employment, all such files, records and documents shall remain on the premises and in the possession of Company, and you shall promptly return any and all such files, records and documents to Company that you may then have, or at any time thereafter you discover in your possession. You shall not retain any copies of such files, records and documents.

 

 

11.

INTANGIBLE PROPERTY OWNERSHIP. You hereby irrevocably assign and transfer, and agree to assign and transfer, to the Company all of your rights, title and interest in and to any and all inventions and works you create or modify (including, but not limited to software or other works, designs, or the like) for or on behalf of the Company. You hereby acknowledge and agree that such works are within the scope of your employment or association, and that all intellectual property rights, including copyright, inventions, designs, and trade secrets, whether patentable or not, are the exclusive and sole worldwide property of the Company. Copyrighted works developed or created by you and owned by the Company include the right to copy, license, market, manufacture, publish, distribute, create derivative works from the works created, mark as copyrighted by the Company, and to authorize others to do some or all of the foregoing as needed or desired by the Company to carry out its business purpose.

 

 

 
Page 3

 

 

 

You will not at any time during or after your employment or association with the Company have or claim any right, title or interest in any trade name, trademark, patent, copyright, work for hire, or other similar rights belonging to or used by the Company. You shall not have or claim any right, title or interest in any material or matter of any sort prepared for or used in connection with the business or promotion of the Company, whatever your involvement with such matters may have been, and whether procured, produced, prepared or published in whole or in part by you. You further release and hereby assign all rights in any and all intellectual property to the Company, and shall, at the request of the Company, give evidence and testimony and execute any and all agreements or other documents as needed to effect or memorialize any such transfer of rights without encumbrance, and for the Company to carry out its business purpose. You hereby irrevocably appoint the Company as your attorney-in-fact (with a power couple with an interest) to execute any and all documents which may be necessary or appropriate in the security of such rights, including but not limited to, any copyright in your work.

 

You certify that all works pursuant to this Agreement are original works and are not the property of others, and that any liability from or caused by you in this regard is your sole responsibility. You shall hold harmless and indemnify the Company from and against any and all claims, actions, losses, costs, or other liabilities based on or arising out of claimed infringement by the works of any copyright or other intellectual property rights of any third party, and you agree to cooperate in the defense of the Company against any and all claims, actions, losses, costs, or other liabilities based on or arising out of claimed infringement or any other action by the works of any copyright or other intellectual property rights of any third party at your expense.

 

You have attached hereto, as Exhibit A, a list detailing all inventions, original works of authorship, developments, improvements, and trade secrets which you made prior to the commencement of this Agreement (collectively referred to as “Prior Inventions”), which belong solely to you or belong to you jointly with another, and which are not assigned to the Company hereunder or, if no such list is attach, you represent that there no such Prior Inventions.

 

 

12.

TRADE SECRETS AND CONFIDENTIAL INFORMATION. You agree to keep confidential and not disclose to others any Trade Secrets or Confidential and Proprietary Information, during the term of this Agreement and all times thereafter, except as required by law or as consented in writing by the Company’s Chief Executive Officer.

 

 

 

You agree that the Trade Secrets and Confidential and Proprietary Information described herein are valuable information.

 

Trade Secrets and Confidential and Proprietary Information includes all forms of information whether in oral, written, graphic, magnetic or electronic form without limitation. Trade Secrets and Confidential and Proprietary Information means, without limitation, the Company’s client and prospective client names, addresses, relationships, terms and information; suppliers’ names, addresses, terms and information; financial information; business and/or marketing plans; methods of operation; internal structure; financial information and practices; products and services; inventions; systems; devices; methods; ideas, procedures; client lists and files; fee schedules; test data; descriptions; drawings; techniques; algorithms; programs; designs; formula; software; business management and methods; planning methods; sales and marketing methods; valuable confidential business and professional information; proprietary computer software; management information; and all know-how, trade secrets, confidential information and any other information developed by and belonging to the Company which gives the Company a competitive advantage over others.

 

 
Page 4

 

 

If you shall leave, separate or terminate from the Company, you will neither take nor retain any file, record, document, Trade Secrets or Confidential and Proprietary Information, whether a reproduction, duplication, copy or original, of any kind or nature developed by, compiled by or belonging to the Company.

 

 

13.

NO PRIOR COVENANT NOT TO COMPETE. You warrant and represent that except for this Agreement and except as otherwise disclosed in writing to the Company, (a) you are not presently subject to any contract or understanding that restricts in any manner your ability to provide services to the Company; (b) you have performed all duties and obligations that you may have under any contract or agreement with a former employer (or other party) including but not limited to the return of all confidential information; and (c) you are currently not in possession of any confidential materials or property belonging to any former employer (or other party). Further, you agree to defend, indemnify, and hold the Company harmless from and against any demands, claims, obligations, causes of action, diminution in the value of the Company, damages, liabilities, costs, expenses, interest, and fees, which the Company may incur due to (a) any conflict between your employment with Company and any prior employment or association, duty contract, agreement, order or restrictive covenant, or (b) any misrepresentation by you as to any facts which are the subject matter of any conflict or violation of any prior contract, agreement, order or restrictive covenant on your part.

 

 

14.

COVENANT NOT TO COMPETE. You acknowledge that you are familiar with restrictive covenants of this nature, the covenant is a material inducement to this Agreement and your employment, the Company will suffer irreparable injury if you violate this restrictive covenant, and the covenant is fair and reasonable to protect the Company’s trade secrets, confidential and proprietary information, relationships with prospective and existing clients, goodwill, and/or other legitimate business interests. You further agree that your work with the Company has provided and will provide you extraordinary and specialized training, knowledge and information over the Company’s techniques, methods, products and systems; the Company’s valuable confidential proprietary and business information which you would not otherwise acquire; and access to its substantial relationships with present and prospective clients and substantial goodwill associated with its name.

 

 

The covenant is intended to protect the Company’s legitimate business interests which include but are not limited to the extraordinary and specialized training of its employees; valuable confidential and proprietary business and professional information; substantial relationships with prospective and existing clients; client good will associated with the Company’s ongoing professional and business practice and trade name in the fields of healthcare business technology and services throughout North America.

 

 

 
Page 5

 

 

 

 

Accordingly, you agree that prior to your separation or termination from the Company and for the later of six (6) months after your separation or termination (with or without cause) or from the date of entry by a court of competent jurisdiction enforcing these covenants, whichever is later (referenced herein as “the restricted period): You shall not engage, directly or indirectly, as principal, agent, advisor, stockholder, consultant, partner, independent contractor, or employee or in any other manner in any business or activity which is in competition with the Company or which may propose to go into competition with the Company. And, during the restricted period, you shall not directly or indirectly induce or attempt to induce (a) clients of the Company to do business with any competitor of the Company, and/or (b) any of the officers, agents, employees, or associates of the Company to leave the employment or association of the Company.

 

Some of the businesses which are in competition with the Company or which may propose to go into competition with the Company, and which are specifically prohibited include but are not limited to: companies that acquire or operate Internet based businesses. This list of businesses is not intended to be an exclusive list.

 

Nothing herein shall prohibit you from purchasing or owning less than five percent (5%) of the publicly traded securities of any corporation, provided that such ownership represents a passive investment and that you are not a controlling person of, or a member of a group that controls, such corporation.

 

 

15.

REMEDIES FOR BREACH OF RESTRICTIVE COVENANTS. The Company is entitled to obtain equitable relief, including specific performance by means of injunctions, as well as monetary damages and any other available remedies. In the event a court of competent jurisdiction determines these restrictive covenants are not enforceable as written herein, the court will reform or modify the restrictive covenants(s) to make it (them) reasonable and enforceable, and the court will enforce the restrictive covenants(s) as so reformed or modified. Assignees and successors of the Company are expressly authorized to enforce these restrictive covenants. The restrictive covenants of this Agreement shall not be interpreted to employ any rule of contract construction that requires construing a restrictive covenant narrowly, against the restraint, or against the drafter of this Agreement.

 

 

 

Further, you understand that any and all obligations of the Company to pay any compensation to you for any reason shall cease and terminate upon your breach of any of the obligations in this Employee Agreement.

 

 

16.

NOTIFICATION OF INTERESTED PARTIES. You agree that the Company may notify anyone employing or engaging you to perform services or evidencing an intention to employ you now or in the future as to the existence and provisions of this Agreement. You shall, during the restricted period, (1) inform anyone employing or engaging you or evidencing an intent to employ or engage you, of the existence of the restrictive covenants in this Agreement and (2) notify the Company of the name, address, and telephone number of anyone who employs or engages you to perform services.

 

 

 
Page 6

 

 

17.

MEDIATION. If a dispute arises out of or related to the interpretation or enforcement of this Agreement, you agree to try to settle the dispute in good faith through mediation upon the Company’s request, before litigation or at any time during litigation.

 

 

18.

WAIVERS. The Company’s waiver of a breach of any provision of this Agreement shall not operate or be construed as a waiver of any subsequent breach.

 

 

19.

GOVERNING LAW, JURISDICTION AND VENUE. The Agreement shall be governed by the laws of the State of Delaware and applicable federal and local law, and jurisdiction and venue for enforcement shall be in state circuit court in Wilmington, Delaware.

 

 

20.

INDEPENDENT RESTRICTIVE COVENANTS AND SEVERABILITY. The provisions of this Agreement are independent of and separate from each other and from any other agreements. The breach, invalidity or unenforceability of any provision or part of any provision in this Agreement or any other agreements shall not in any way effect the validity or enforceability of any other provision or part of provision of this Agreement. The existence of any claim or cause of action by you against the Company shall not constitute a defense to the enforcement of these provisions.

 

 

21.

ENTIRE AGREEMENT. This Agreement comprises the entire agreement and understanding by the parties regarding the topics contained herein; no representations, promises, agreements, or understandings, written or oral, relating hereto but not contained herein, shall be of any force or effect. This Agreement may be amended only in writing and by mutual agreement of the parties.

 

 

22.

ATTORNEYS’ FEES AND COSTS. If any litigation proceedings are bought arising out of or related to the terms of this Agreement, the successful prevailing party will be entitled to reimbursement for all reasonable costs, including reasonable attorneys’ fees.

 

 

23.

ACKNOWLEDGEMENT. You acknowledge that you have had the benefit of independent professional counsel with respect to this Agreement and that you are not relying upon the Company, the Company’s attorneys or any person on behalf of or retained by the Company for any advice or counsel with respect to this Agreement.

 

 

24.

NUMBER OF PAGES. This Agreement, including the signatures and excluding Exhibits, is comprised of eight (8) pages.

 

 

 
Page 7

 

 

 

Onfolio Holdings, Inc.

     
12/15/2022                                      /s/ Esbe van Heerden

Date

Name: Esbe van Heerden  
  Title: President  
     

12/15/2022                                     

/s/ Dominic Wells

 

Date

Name: Dominic Wells

 

 

Title: Chief Executive Officer

 

 

 

 

 

Employee

 

 

 

 

12/15/2022                                     

/s/ Robertus te Braake

 

Date

Name: Robertus te Braake

 

 

Title: Interim Chief Financial Officer

 

 

 
Page 8

 

 

EXHIBIT A

 

Prior Inventions

 

None

 

 
Page 9

 

EX-101.SCH 3 onfolio-20221215.xsd XBRL TAXONOMY EXTENSION SCHEMA 000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 onfolio-20221215_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Entity Registrant Name Entity Central Index Key Document Type Amendment Flag Entity Emerging Growth Company Document Period End Date Entity Ex Transition Period Entity Incorporation State Country Code Entity File Number Entity Tax Identification Number Entity Address Address Line 1 Entity Address City Or Town Entity Address State Or Province Entity Address Postal Zip Code City Area Code Local Phone Number Written Communications Soliciting Material Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer Security 12b Title Trading Symbol Security Exchange Name EX-101.CAL 5 onfolio-20221215_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.PRE 6 onfolio-20221215_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE EX-101.DEF 7 onfolio-20221215_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE XML 8 R1.htm IDEA: XBRL DOCUMENT v3.22.4
Cover
Dec. 15, 2022
Cover [Abstract]  
Entity Registrant Name ONFOLIO HOLDINGS INC.
Entity Central Index Key 0001825452
Document Type 8-K
Amendment Flag false
Entity Emerging Growth Company true
Document Period End Date Dec. 15, 2022
Entity Ex Transition Period false
Entity Incorporation State Country Code DE
Entity File Number 001-41466
Entity Tax Identification Number 37-1978697
Entity Address Address Line 1 1007 North Orange Street, 4th Floor
Entity Address City Or Town Wilmington
Entity Address State Or Province DE
Entity Address Postal Zip Code 19801
City Area Code 682
Local Phone Number 990-6920
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Security 12b Title Common Stock, $0.001 par value per share
Trading Symbol ONFO
Security Exchange Name NASDAQ
XML 9 onfolio_8k_htm.xml IDEA: XBRL DOCUMENT 0001825452 2022-12-15 2022-12-15 iso4217:USD shares iso4217:USD shares 0001825452 false 8-K 2022-12-15 ONFOLIO HOLDINGS INC. DE 001-41466 37-1978697 1007 North Orange Street, 4th Floor Wilmington DE 19801 682 990-6920 false false false false Common Stock, $0.001 par value per share ONFO NASDAQ true false EXCEL 10 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 11 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 12 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.4 html 1 23 1 false 0 0 false 3 false false R1.htm 000001 - Document - Cover Sheet http://onfolio.com/role/Cover Cover Cover 1 false false All Reports Book All Reports onfolio_8k.htm onfolio-20221215.xsd onfolio-20221215_cal.xml onfolio-20221215_def.xml onfolio-20221215_lab.xml onfolio-20221215_pre.xml onfolio_ex101.htm http://xbrl.sec.gov/dei/2022 true true JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "onfolio_8k.htm": { "axisCustom": 0, "axisStandard": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2022": 23 }, "contextCount": 1, "dts": { "calculationLink": { "local": [ "onfolio-20221215_cal.xml" ] }, "definitionLink": { "local": [ "onfolio-20221215_def.xml" ] }, "inline": { "local": [ "onfolio_8k.htm" ] }, "labelLink": { "local": [ "onfolio-20221215_lab.xml" ] }, "presentationLink": { "local": [ "onfolio-20221215_pre.xml" ] }, "schema": { "local": [ "onfolio-20221215.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/currency/2022/currency-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd", "https://xbrl.sec.gov/exch/2022/exch-2022.xsd", "https://xbrl.sec.gov/naics/2022/naics-2022.xsd", "https://xbrl.sec.gov/sic/2022/sic-2022.xsd", "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd" ] } }, "elementCount": 24, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2022": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 23, "memberCustom": 0, "memberStandard": 0, "nsprefix": "onfolio", "nsuri": "http://onfolio.com/20221215", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "strong", "p", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "onfolio_8k.htm", "contextRef": "From2022-12-15to2022-12-15", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://onfolio.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "strong", "p", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "onfolio_8k.htm", "contextRef": "From2022-12-15to2022-12-15", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://onfolio.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://onfolio.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://onfolio.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://onfolio.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address Address Line 1" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://onfolio.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address City Or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://onfolio.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://onfolio.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address State Or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://onfolio.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://onfolio.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://onfolio.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://onfolio.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://onfolio.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://onfolio.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://onfolio.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://onfolio.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://onfolio.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre Commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://onfolio.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre Commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://onfolio.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security 12b Title" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://onfolio.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://onfolio.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://onfolio.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://onfolio.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://onfolio.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r7": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 16 0001654954-22-016711-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001654954-22-016711-xbrl.zip M4$L#!!0 ( *94G=;HUM)D@T5!MTHB@U=H!TS M:V1%7[$V5/E^AOXGM3-#XV 2C#X6[Z^Q!I84C@/"J)#<@CXDEXA8S8X:C[)N1EI)#3 MW.4H?/YZ_^1:Q2MZ!=JA"1Y-I]/027/H$;+>6%;\ E]7H1FD[ 2>"?NEDQI^ M<5"D#'P6IL(:E#5"SU,H*QI7)L*HMKY-A?6:&'6BY" MJJ%,6_4*44WSPJ@# M0DT_B$,KMIR1;<5Q5#5EFZW%E!/535'6'#$(:D"1;'[@#2"H8J0@2-&!(X5_ MP ,_&YUO&AGMXZ(*EF(I.9,%.%L'1&X<+AI'9QXJ!LP7J3:W=(D3#HXDXO\$ M<[9D]L.EG-HMI0:HB U6*VH>\(;J&!-ZVA[,8C3'0DCC]A"[A'4<,P"[!9K; M[V1F2_8-4H7LP]^/=XU:W7RYD;!E>HC!($H?4S69G@5=,L& BM:DA@/_Q+7+IGV*DT$)WK=IO(F!FDC44P)PGO22J]:>%DK_)$59.7 M3YI'ND1N0LULUUUXFFUB;N>)>[=VFUN63S^OT+\08P -E*.L_A-#RI7@,"V9 M[5P%' 6.M!P-45 B8ZH,@R^UG)3ANX7%\4O?L(!"^<\:#S15WW@.^O!GC JZ MOF]4]0_EO8.:AY7A!(O:Y)I#2%(9)(YFWZG=/#V*WDOB])R@V)6?\WS[RH_& M< +]GJ1^=?'@S*T?A[DO+X>-!]0.MK."=;H67=SS0>7)IOZ%"5?N,8<8+U^ MW.]FOLHI5@,=*$\QG6SG9#RG1%GUJ.RTZ?XLGP[P8YD+; M_:I3_@N\>QI8 7?\SN8=' R)\>D^YG"O-E*]?H%UMT1PI6I:/I=*WE26A@MA M5W>JK'?SH4J)ZN>W4%"4A?1PX"LI?!3I9S>'VH;O%UMO629M'UYR0 MOIF]H_1I66QAK7G;H'*P,L@Z AZ4!VJ:T2SQ;Y9=03M=N8X9!&9X M+1QRUQHFH40K]@J\<3@7E,/B X=US4S##@8;ID)1L#BZZ*JUTH>3$?O:P4?^ M"4(:V-!O#]]AV5JAT%K8:=D&*_8S;!2/8"$E%(%AH4"+YHCE14X*]2L/GV=? M'_A&*YOW5LQ)[=PAC^.NZZ)N$FFSC[,D2>.GQ^V.U]X7%2HTG",964'E7[QT M.IW&0W2$_H7LGXT<5D/^5QIQP 9N< MGQ3HG]_AQ3(,X8/RV),?FDK[ 0P^S@9G\&ULO55;:]LP M%'X?[#^<>0_;8+)BA\(:FI:TW4,A'2/=1M^*(A_'8K(4)#F7?S_)MR4TA6:0 MA1 V8=&D):]*_&9P1I/(P' M7_K[U\QZEE8UQQ>3OG+K]4#GP(-R34U2D@[\-TU[T(/.W9H9!&9X(1QR5QDF M(4,K%@I\<&@:&L'D X?;@IF2+0V63(6F8+)R<:]UHY=;(Q:%@X_\$P0;N"/? MOOZ Z\H*A=;"@Y95B&(_PYWB,4RDA%E@6)BA1;/"K)630OT>A9^Y[P_\H)4= M;:P81X5SRQ&EZ_4Z7@]C;18T'0P2^G@_?>"%ST6$"@/G&'6LH'*(EYR?G].Z MVD&?(3=S(SN/(>WB],J^FKF>L L^HTW10ZT8V3K95//Z.;S" 5Y$A'^D@Y%P MB_BG.DSBCE.M@NS8O--G-+G376!=> MPO!JCB03_F4)[T$$K=%N;[V*4(YZ*&TQ]*# J5/W5B33)1-'1G[./GG>VH>4 M6,[#@SXJ[#[UU$F9E,?EJPFG3J6TFQP;K./\Q[6(.:ND^^?%V-%W$_N;0HFP MMTW]W[W4N'&H,LRZW$'NE7N1$RY@!\TG ?+WL"10(^$[6Z _27+M3Z5@W^R M72RI^5X6&39@;9Z/T':]6^3Q0J]HAH*&S2]&ULS9O];^(V&,=_G[3_X1G[ M89NTD$*E:45M3Y3KG=#HBPJWG39-IY 8L);8R#8%_OO9>0&2V$E;W3F1JI;& MG\?^/GZ^V XOE^]V40C/B'%,R56GUSWK "(^#3!97G4VW/&XCW$'N/!(X(64 MH*O.'O'.N^OOO[O\P7$^WSQ-X#WU-Q$B D8,>0(%L,5B!:KISN,",<=)Z3^3 M<0;0[YYWSWX_7+_QN(RB)(Z1C;U#RWO9'] %^*KG.+37=_IG\J??/T!3NA!; MCR'PF+_" OEBP[P0 L3QDH 4#DE" QC^Y,/[E<Z.!QTY&P#)?# :HB>T@%CT0.S7TE$<1^M028JOK1A: MZ*6$C+DJWB5HJ8RFAKE0P_1^4\/\F%Z>>',4=D"1GY[&QJPNX+I;ZN M\T?$, UN23;*5TJTV.U+Q7_5X:?"8^)-4UZ.MYS C HO?)/TTTC+HN_1VV;[ M&&=[EN6JC]XVRR>1WT"T* M^]=3JYC14ER;R44X@V@E$ A1D$E4'%2MNW'^\ ML,<]'_JF?J[74*W=E)7SYK+7N$>._.Z2/KL!PJ[:S]2#>/^,4Y;_?!E1>0 8 MSKE@GB^RGN(DKCJ:=CJ)0$NH4A8CS:=JYCAGX)Z/^ MO72/O7SS$M\2@<7^"2VQ&IV(>R]"FCSTF)V"5TG,ZJYC6E#^"EE%%R0H'%E0 M< ->&,D#NSPEC^62M/L#[8U9E3B;;C"(S-NA +7&#WI=!D.D,,0T2-RJ);([ MN)GL49-/OMF. 722LKJ?MK6@W!HYQ2H?;I$58[6T0SELH(;^$'I+C?A"NYWB M:D5EU-!FR-9QXI%U[X-UY7WA_IX0:3#K)C!;.\S =E MH@4F,(HJ.N (0D9:+?\C0\I\2!8A_KB ^C@@>U@LM+M!%6S'#O5R,UN8R1;8 MHU9B0 !@ !O;F9O;&EO+3(P,C(Q,C$U7W!R92YX;6S% MFEN/XC84Q]\K]3NX]*&MU!#"[+8[:&97#,.NT,X% 6U7?5F9Y!"L.C:R'2[? MOL?ALL.0!/>A>#3BDOR/??X_.TY.PLV'=<;)$I1F4MPVHF:K04#$,F$BO6WD M.J Z9JQ!M*$BH5P*N&UL0#<^O/_^NYL?@N#+W>B!W,LXST 8TE- #21DQ>VR/R!F);8W,^IRNA"04:% M-46Z2],\M-63BXUBZ=R0G^-?B.V&#(*G_H3>*-=3Q?=]7(7[=%"N64<7 MW3W(N(#K$$8J%?9;L)<%=E. 0W45-=*0SFP7.4,VR!4>+X8M^ M<< USM'"Z -N. J M0&10+)OQB;@F)EAQFI;V[^(!-\.AX 42C*D*>!"2<$#OWPM^NU. MM5$T-ON6.)T"+]K_BII7DO!_SZDO$-5F!"FS?0KS1#,H3ZU<>9SAR^'LJIA( ME8#"8=BWB$O!T2">3MB=(ES@RB%,@"L'/XS_3,FLBM2.BSR3[DM\V-7E"/?0 M#2Y_ YS/Z\^PJ4-\(G5B''EC7&'MHI#W1_<$6RQG>ZQP0MKV@+3,R$5)=K'W MQ&;PD=.T'.4KB1/+*P\L2ZUX./;[&:@4KW0^*;DR\Y[,%E34K@ 5 4Z@WWA; M!VIM>ED-AJ"83/HBL1>L]UX=2:S[F]GJ"9U?-+)IM3K43NT3M MA/HW?[.ZTJ 'VEC:2+60JL S1DK0DSF>?3<]F=1>MIT)=!J#W[V-@9-M#\/Q MD7%XRK/IM[JCC/U+E1/H=]Y GQKR0'5"UX,$W; 9VU; YQ%7ACCQOO;&^XQ5 M#_"[28*0].X-2W*(ZL"7RMWJ%7]%88U'?\1[^/%93>1*./!^*7:C[:\\K/3G MCW5Q"GE60R67;'L_[QSPDP@WZCXJ2!>G_M /I3:4_\T6YZY8RO5NV'T4F^== M7A2Z/=RZ"F@UYF.%&U@?Q669DXNBM#?B^7 N1>VUWJG*#:F/(K+*T46Q_J68 M,2!Z,LMRL;O\T>5L*Z1N@'V4CK7>+DIY+#F+L7@5Z2.>"12CO!QQF$.%=@A!CRS%O=L[=,J]3R;5:T1=7HWV#Y*P_,N?4(?:)V#^J_H2Z+< M!L!'K>CJ^+(+"\0YKG*;J#V=V(>M%)FD_74\IR*%ZJ?;Y4HWMCZJO#IG)XAOPI/\'W"#_37, M=H]]L;\0>?\O4$L#!!0 ( *9IWMV3-T3_&PX!<,ZFX"#]LN(72 M!F&A)WP>]C]LQ+KG[&_\HW8TT- +>H:JRLGR,. A^RWCY=?-Z;=]?+^LZY%+6FH>D(.J08L$-*N4RH[Y;T,$$*@T#3TV'06(7ZV> %O3K@L],V0O[12QN4O5 M##*T\AOZ+V "K;[.4R7IO%NTC;FN?&G7/=N5IUU]QI<3&AJR-*Z&\7 YLKZ6 M13V)6!%Z,,F]Z0 1KC%&A,[<.,EZ*ZFR5X36J< I42F[[V\BH>V1#HB5(T7 M9O+2HZIK>JAAA%.!]:[03S[]&%#L[$N6G4OUHZ*=O:N M\"=$Z4G ; >'!KP?5G^/E>:]R6$/!E?=4J2)YD.F2,A&1(HA#0%]GU\G(]_Y M7$4!G:! L\/;@#E\1[C_X1TNZ*3YKW>U(SZN(F),VC^Y[[/0_ F@SZT6D) . M 5O0OFHC!$)-ZK \28-FZ+/Q%S9)ECS6EZ@FIS /TMQQX;]=+69_;]1*8-CV MR[N5W?)1,3?%ZAF/@1<^\N,TH/VU9R+6FG_8 ]0[0K0(QKV: "6KF9^+4Q? MS"\>5)JA36>J=H1&LJJ,*89IB;&O513M#^\4'T8!>Y>\&Z"9>)?(GI/*76&L M?*!S,0_&SIB=QCPJ$4OS9"QQ-5DMLNQ&NB;=F>%.^L1]?.YQ)HF9EBUU@_7F MESQ?Y@?7TE=YZ!'03?CI$[@%J4] 76HSM-)QL[8IFOZ*KFE+^IQ.4LR1(X43 MA]R2YEO[9$J#(:,JEJR6V-DJM*7#TZ;T&<GS6_/KOZH)1)6?'EY^:YU52@O60)?9XH_;W7]R]TN%1,7KX23S0 M3"9Q84I+$?9KW\Z;G<8):7>..XWV43%Y^S1SMQOU;Y?-3K/1)L?G)Z3Q6_WS M\?FG!JFWSLZ:[7:S=?[$"'VG:@!)B1;A-CDIU ND7-JM'#PN$L_#]B,5T7") MCNU'>J-VVKH\(W->=EUG.O/&:7!D(IW:OO-ET9$B$K6W2%Z0Z\O&>8=<-BY: MEYVWM,*+;Y?M;\>PM$Z+@/YV0$F)NT-:E\3=W?2W2.N4=#XW2$:UIVI]7.]@ MLWNP4WD#A,#@@X@>N621D)ILIL^,@JMC2A-VC9F!-,W,WZH^G$9=F%"G80.@ M?/SJPYLA ![X=#(!5!@D R?,8\,NA';N[C9!R(N*^%3"X*(^K;.5,I& M#"D* V8&NA F;-P0$;C3B,!"W]G[]?":2?VJ3YGF]L)8UST9YC4]X2+A6Q(-(&,9MS:WO6:+#)U.G_=U'5:?2\ZG3PVA, M,_2$!$-OBL)M#4:X;@ML=>'G+336F#'-U2R2XAKA6!,=T!%8ZR5*-:]-\PJS M^VN.4'-,-X\].N3!I#I/)/=+R?R\01Z>\H !#'"46.1P MG8I;V=M[^0QY>XSHT'$S*2EY1J%2KNR\=]R#]_M[!^_78,N:7N>I?8TQ#D1( M(O0 0K+?8\F5SSU<)CB?++\?4X:>>M5U,1QRA?M_;W6%S<)EH5T@C6$4B F3 M+UT.>=9A&7&4?1KR/\WSUAME$EIX8HW)6UUBWG N+O;F6/5>JR?W"DDQ!GVN M>'153%.9<^4OW&\>^[YD2B6_OO*0N1LUMU1Z3\Z%U /2@IRFSTA;2\;T-JG MJ]- "#GO3+?O7ZG((52'/UNR(T80Z'[GP=!66!][5N-H6_("HFQNCB'<.0@G M:P1];NEQ1>7>\?GKE.4+ 5P*_L,CDT?5W(/]DGO_V.\QXX $<2PD1!($CT7RQ>;9FSZMC??]DON^\/%70+ M6#00(2.A<;C;!#@?Q.B9"!@4"FK@,Y(KW1G(/O.2$*P:A^ I\909T/'>.H06 M]QCFM5JSM[]0\=VZO[']*B"JNH$)R!=JI&>B;3[0 V@SC0-.0 MB5@%$Z) '55O8D8F T07)DX2)0LR4R(V>DMH.$G;>B* R7$7I+Q3*D#'Q]:I>Y.V#>&@!^B'_3-0%-"6X,'I.IN" M#),Y%HGJ5B@@EZ%K8VP-59ZJE5+!]GSQA+V0#.45#^>9 P]H6V2KUP.G^- $ MAJD<+S/7#R78K?A.>;.[M1ZY;=_71O"F4C&3+XOL.\RI;'KKD3WI^R:<%UF*XI/T^VZ[F MH&.^SE6^39TKP4V+:#7B!HO%UF3":GEZZG)GY]DVECIXXMX>KO$&Q(- 5MU8 MD[EQWQOG5/GTCX6=C3J-N(8<[8S**Z9_FJY% MT_6=2JSS*-(1Y"*60&_%2-;X_!3NO'"C ?C^DRAYHECUNUG=WL0NR6R29NAC M>LSPFUC/5&I!K:X@;F+FX--<&94K0D,"N35J7I_TI1CI 6;9$996J2(^Z_'0 MGL*UE;G2;IH[SI7EX*U[L+-#-G&9[P]-=2[MS,WYW0C/[V+)W*;JY:Y37@(K MEZ];H)4I4$S;9^,R8 NO-XDWF@)3-%9PX8&V=E/PGPSTN@6^7L5F;T7%YK%% MN7>#<.)>WU))YPM[!> [" N8AU^*A\(40V+P)M@+IDUV)/!^"6X*)/:+5B2, MF2N8X.0C#E,C-W %T"+9-5A+^J$K.S M2:>5F*S8%QZ,Y^/.=%WVZY6[ENB>J4ATS\]05WQ2>I=/5^?=Q(]K6DB.HTCP4)M*.+0LCD.KSD*%'X-/R+$T M!\^PMUK6_;5^'IF3X,KNRGE;(5GX!&^;_)."H_A>()_IZ(J'>(8$=PK 0F,T M(9D"&';/&9Q&?.:_$LD#-9L(1+$$T.O4! EHK1"# T[LQX M.Q4'1BC01_E"[LDR "8^S&.\30F!@Y2%\L03%.:<$M?!16#,A"R!GV?-[E/K(]LQ3_I&%,P;A;.[&3"%=6W!+\U,W" M72#'=T)EF\Q+(VA%(,MS^@#@] [T7AR9,,"-Q22;%]V.31X.H#>D$>8/$\R3OKA99R^S& ME$ZIW/5 \8P:&E+"[[^0W>@ +1D>(P4+36@NEI+V>(%)\XSS[S(]0D>1UPWD MN#FA9M@"GDC-GUFPNUD#-F=8[F8E"L2BS#$L(+;&:MT[BLB 1S] TT_,U?;" MN6EX)=(%D.2Z(4 3$^2! +V<$RM<61=5$6!/H6+O!;AI\IL,-"N80ADD\8TI MYID2%/I%!(^.CUK)M^XPOR#CZ4O'EERD[7Q9?@)M67GJ+Z05.4J#,01"[!P85AD'9V27+HGO\N%E? 9.V$8L1)-^G_>560J=3-6BEYNL,#<&*;O[_P3O%#%)' :< MDN-YJ*EGHFH6H/2DU0L@1OVT951;<3 $5)K(TI#0.B^498@_TU8>^L!CF3B. M7#P!,-S2SLX@((RZ\ 6\R15B!)H!KI#9U1M<@6?:8^1H!/4IV$ET-A6\O*ED(EE*W MN&1\\U/7AKC >]R#4)? M<)//12P 8ZX!\O00OU%EQ#O]?ADK)B"'W#C_Z269KW@;9D7M[J!0ZECJ]B,,N]:[Z$/*%ON.)0,CJ+Y[' MP",]PQT1&?M#B;FG>".YI_B_;.R6W,) #_&[VZWEX_I*HTDC=XO'4 M+1J7Z1[F"WUYRMU*+GKFYUGEPBU5_GILKV.=CEQ@HFGJ'S39,:&:$G.QR*;= MT$[J)DWS3T:8V^!?Q.?0KW6;>,ZB=P/<-IO9=?)S&_G9K@V^(9YO-S^='W>^ M79HKI5_S);_K)M47F6*>W0" DQJ_\V MP^A'N=<)W#!*-'Z)M:8KNNM'$XG&K+A]=N2;#Y.O@9YF MEL>^QC$1[?*C3/,PE\[=$1F\E;HZV^LNE]);IV\=Q-T1@8^3ZD,FAW?$HJB* MY 3WJ+A'OH/M4L^JJH\ARL]X;]Y=13/+C^V?#'EVAJS8\'\"SOS,PIXL"WL6 M4A>3.?$?5:O]#U!+ P04 " "F7)15G/"0FS0C "$SP $0 &]N9F]L M:6]?97@Q,#$N:'1M[5W[9)GTSRU^?^9]T>'1_?@^\?W^8O'_W5P<)K']<)DE8H+HRN3J+JT MV4Q%IR_ZH]>ZK$QQ;Y(G*U56J]3\\[MQ],OXH/]J\&)XK%(SK4[4 M\[/A^%@='2XK5=F%*55FKE21+W3VW9/'2_<<_NK@8O"_$?^4'SMXWG\]>/7K M5P74" Y=5D6>S)]$O+P=/!V,8 M\][1X_ORX>/[RR?JLT\=PW&9 N;^:S8IER>W/(G?X.OS5V>_1I'JOQA%T>MH M.+[E;=)+O85-$N$,AJ<14LL/CS;/.I[;4O5GA3%$G'O5W*B__N6G!P\.3_RG M]/?1R;Z"GRYT8I3.$D7'!F1LLRI7NE3_TEFMBY4Z/%(/#A\\5).5.F-^4"_S M- %:+]4@B^_UE%:G)M57NC JSHME7NC*YEEKZF?Y8JFSE9NX![/$:8V#*%N5 MJJPGI4VL+JPI8;SIU*86> K_79:P.4/_A$66=1R;LLP+^-OH>*[RJ;J:YPN% MDYOWRP*^3%=*U]4\+^SOL!W8C(%E%[%15>MH>$!XF)XMS!1VG\7PQ!S^83,\ M ED\[J.] 7ITE$],4=4EO 3UM-#ZG>G=.,PJK]WC>1%\6*Q_&BV6:;XR1KZY MMS4ZK?0D-6Z:25XD(,7*I8[A11W#033/_E:7E9VN3J9Y5AUODEPG"UW,;': MDQS#^\C=!R1_^),KFU1S>/KP^^]4;-)TJ1,DB7]^=_@=KJ5P"YD;>N8(2)Z^ M2-P7/, /WY]L^/L2Y MCNCD0>HGK6EO:;9G9\.+P6DTZH\'9\-[ZM>\5AJI%0A75QWJ1=9M<2R06IQG MP$5&V \X PEW45>U3M42IK,E3 T_JK3-Z+'NF$C5.3Q4J%F>)_3GI4YKHHG6 MX,P[,,"T+NCW:U,C72M#9$Q# VT#*^>QY5]P=J9GD^)+R2LU M!&HX9K.V(1"''UKB%'\ _TW,U&86I,32%!;.%=\,K*JA+?B?XF:"_\/4Q;QK MLP36?OR0R*WA>T_@GX&(.Z-^>&NWS%0/MLK"H^A\%%V @B8>OE#]X:EZVQ^- M^L/Q(+I@GBX,JBG';Z VD<)03X6T(RQO@(C2-+]"15E60-=(>R5IK*JH67&# MSBV KED_SC4P1&$6&KE[[1?P__ U;R"I"QSU$QGUN/UFX7]0.NR4T[7*Z:?O M/PMA;6#6;2E!O54.Z@.!AI0.Y.L9ADBRH\*(?O5RF<):B&)1ZEY/SYLXA^#< M-H7Q[KU?$WR[]WQ(A3K9*]AT @GBJLE4--A"85ZF9Z;2'6,PF#+TF\)I1 M>NLV=IO FIC.Q>8AB:EGP"UEA:R"'*-CH/M$@Y'"TAT-,,1-Y58!R1WD@489 M_BDUU>UID(=;9:7SLXL!HB\"7Z=O&'B- VQ%3%.29X#T!#$&.CT0(I7$#P,T MK>Q"/9M;,U7/P:3(0(.DZFPZM3&8#68Z15/BTN #@.<;9TF/O"6,]!B-3="[ M4"[10D*J0/VT9_>!876Z^AV9>%(G,\,C3^N,K#UZ$K=$!E\">T6A6CJ3$0\O+NP$X,1DI3J^GJ._GY1"!)$_)T<$ M4Z ]MB_Q*-&BZ]KL2%ADHI:FN#1MXU"#[)W6*7JKLL2]C(D!.>W,9SV!G5Y339+UZ@--3-4B[@KY-;-$8N#39-2MW7XOQO3-$MR"6?MBN$'S5?Q:I ML^>*O=_H]0YETM(4((<63&?"$HZ. (@X_V/H&ZK4/%^8'@+J34P"GV4'<0V M&GZ,08]_@T $=H=HG.Y M!B : &PE8(PUT.!0Q]-<%TF#.4).@#\6MJH,2%_S/C9 6LNZ*&MQ&^JXR,OR M ,8XF. 8JJ1- %,E-0,@C*@A,$"X"'S'0 @0HT57B0,'I4,%(OQA"[AX](+# M!A(C&V H'1P6 QP$4GI%O(*L"Z,O[,$"CG\.[#W1I2U)*"X!.+FNZL+T-EFLF_0/8$E MK![6$:1HXHK ,^C[+GWU4J/ZT7% M?RX'XE27)7RQG,R+9BV?I)N>GHU.H]'!T[/Q^.SUL9JD.GZGCI9@2N2I33IQ M:*]M.]'W<[ 1U-''*GS_+OZVA.<.)D!K[P[T%(8Z!I*]TJOR;T\^!4!T]_T5 MO?2=RK@3#CM2&7E6E\>*M,6OSM2;8)S1SKRMCQ%&&]LEBW*49B#MG-1KC.\) MCJ66J:;?L'_A/XS1W%-]&!KD8%Y7H 52"H>"HJ!A>)Y\B:9VG:%YZ58-W&W0 M&JW$E@2KV(3&)"FH,-BZR!,[M1_4:2+0;4$S! /O_(T[GWM[QGCK+/P6>&O<-OJ6VR]KO,D&^'0K#ZO2F# M? LW'X/&3IY#8?Y=VX)Y^$K6BQR6ZJNO%]M\I6KN]M3/CUM.-!B\?OIF=$'Y MC/!.1^KIFXO!,+JX4-$O:)2CT_NBGOR&:D0(42^717ZITX[[K]>B-_$/P8S+ M*B4M@NJF,'8Q 9N#\F XL87R#'299T0&$\Q^-66)27A@M\"ZP>1!;Q")?W$W M>5WFG+"MF-4'/% ]F /X)X-%67*0XB)A8%198!\ ^W#HMYG_H^R&)6#:V*Y9 M"3O_U*V0[=^WZP3M#T[5>/ :':'/*1ST-!I&SP?CBTY\!H,G56J\R"XU8AB3 MF:G%> 1+<\0U^71*5.NX98X6$5@G^ 7EXK5#"#@>AI-8R!NAZ?*>&L(GE/R: M7>MP]8PXMQ-;M6,'J)$(?:UP$/3(2MX;1X16R.$XKYO1[87P);,&AG$RXC8= MY+L1.+.<0@_FQWG;(&6?]IN.D(T>CT8=AR[/HC0,D:Z MZ >U]4+3HD T^X1,52\Q)]SNBP8PNII++),^N,Q3$.&Z@)6IU.A+%_&2$&U; M9;DHI:XV^X+:=D;/9V*RPNJQ-H#/\+]H),6Z+K^A",6?/U'A3^ZJV+YW^UR+ MZR!38ZL6@86NR8V3A3F M M"(['(&8%?4J*[G15[/&-@EXHJOFNWU)*U L"NM'-?JP:ISCGC0&(3:FV3M MSHGT<$>7-N$?@@@J:[#9_!"885C6$W+8)YM0J#L=CSS;Y^\3!U *FHWR+7@[ MN)T7F*P_HK-'H6:G;0CBWE.Y]FJ=^'N&XB^,S'4@D0O/E>BWIXV0&TM>H@+S M%(P*^%V>X6L@83W! (&\+8+E\.2*TS4,G@LFCKC?=E;4MDWJ)<4X *Z\MXMZ MP8H $RSV'NXK"C"4G?EV;J6=6^E+>X8Q_GU>%\L<)<)+0$CYM.>*NP)V=95? M)(87!K$YI88UL3N?XMS/,N2R,/ &9+_("THURM04&73OT3[*K9BD%,-U^K(5 M+LS6(X:MZ;KRZD)RBA[U&*XA+V)V'*PF05.A;JU33'OR&4C2&V8Q6?8(X-]E MY3F=GH!#LBRM*3..IXAAV3/C1UV"6$8?>BK9)"P3TEQROIMC /515*L#/HV' MQR^$(E HI!QNYY*>D>1]Q8H'3GBBO8S(EH!-)((KT7 M )@ Y:860YWN]V!BX>*=3L$5S%A5=>L_<%+8_,-#)>:EI(3%5,WU+LNO0#;/ M:"C2BZ2"+NF]A\/0*BC)3=8'JP.] A^ZD47CL>,1+$3T[1>@*A,V9&&'B>5T M#%"E?F,-K-^D4]"JO3(IOH*C!Z&4QA$EZT/E,6<+\7F$.LRB&D,L@(J#=M8Y MJ(E09OB0PR!+YKK&+-FI@^T8"W<^F/U@%\S>68C;LA#C>^IKPBQD(0A:89NQ M02NB)BZMI!Z#D@05@T)]5MNTHOA!EE/5%F8WHZ!&*P7T2EPYFU2K*6CYF,3&__YX:%U>?%KI.7/(6/T@E.![RP#\JPYXC0CA!?,4I7=%$K.]L MH6+@C'Q!J;"HS[!6#?X0YQ>V/J@ FKF4_<(LN9W(5-NT+@CIN&Q=AZU8D0H2 M0IU,$4%=-@&9E>2"-QYIB=ZC%'(PQ H M_K/QX.=!4^G-SI3$7.8 E"GSDCDW,]C$!$TX[XG"^7H*94O6>*Y,9F!6;H.B M %"G^%_.XD%)6NG4U\YH;V6Y2A(W6JDT"+*26L'G7&'9$VZ3&"UX)LDI0,7- MEE!'Y-DTM3%E5%AJA%&RU,=9KVQI^%.,RC6[%$&JL\ ("V+1KL*FE#(F,7WD M#,,"S6\G5O E8UY'AUO.J7@&QL*%.GL[C$87+P?G4L\5>W-;BJTHUYA9-"CV MXNJS%-D52^V*1!A'^H25B"H,\00PQQSU3IPO5SWN2E+DF8T];\V9W?.K[L@2PAGB/74!)4'C/'4(Y% M16C&Y\)GXN<(+P8)"2V++%<4"KZ M45N'_O>/&K?="R//9#N&V^!(_QKZ#("+\3#2.YZ=OZ,3Q"@,X%#&&/3^/VHI M<+8MD+,2 8I%4T *EUQ6%7:L00HPC%GPQQC,Q)+,QB'F%QVJ&I20L$ M( CH M2_#BA]_"3J!M0Z!MMZ'48#CN#U\,GKZ*U/GH[#P:C7_M"C%$M! EF7;_Y%1Y4+W&$_)YXR4!Y%E(3U1&/;S)6_AAP%AA?C M(*92#!81\''J'YB%TU_ ^'#Q0CZMJ#&=0P8\5@] &6ZA].6, MJ7UG]IUM"I)@8H"AIMU"V?#( K70U03$;;QH+?!#9 UP\=)LB"EV4KI[C8SE MXZ@ _)G8=?)BB>Q.M8F0HCZA3WO!"09[E1>68"0/M M4JA ',8OJ=8=.PQA;@7L+4VNL#@]U ^MDWKFUF+<^P,<#)IFR9K,-!;VIQ!%NL"HSU W:'B=I[N;T=R[SS1XHE^N/-$_XE\ M'K?DB?X,H_J:)=2:(?J4H"#*+0=!/ZDY(T):DO*IM@M.#6*UQ B W+\A %B) M6LHT>D'HWRAZ>Z*6>J%FH\P15-1S6S!NEGI6T/JI=F!#K!K+A@W\J"[79&L7 M.7_ZJKV7$0$).X9=0#8O*NEY(@E2;@W#AEXXMG MZ8V(?[K)G"'@P0OA_B:TI8DQF>MV*]J^ -Q/U?CPKZ2.^5^R6%P *T]>[=4\ M=[NG8C;1V7QZK@%H83"LS!#! 21!B6B$\3NQ60?E;8(U;1S9:]H:]ERZ)];# M2)^4UB]GJ-#-I0OJHUZ&G]E%+G-RL9UIK<%GFI4-)35V6Z.@L5D0U^3AJS:+ M'%\[:GL??7=(F-('>+\NN _>>LU^9Z[W9B\Q_2]V0G=:XW>[DS2SX0F.T M^Z:K!NDS_@S3=;HM>LF6L2#8M/LUO1_X&$^PZ[)A+!J:$W"LJ76=A0CWHL33 M3CQ*CSB:%6 JE6\*.1'R;R7UM"0HQ: P*).2MY>,/!#C&>^O4[S !A.WI0MI MC$0OKC<6VR4E/P%'1H+]TW@DQJ:HT8QK MW=M@?9'7#:GY*6ZRNMQCF&Z40XQX<"7DC,%$V6KD_^BYU$R]_( M,]W2Z2CM,HLY3_8.,3'I6)"U.IY+VW>27Z5Z7#^)WG/U3O_Q_?I)C\(DE!96 M:6IJUG%V]+JLC>=(=F4YM\N>LZ#%FVP7F-5EY*\UVUZD-+L:R5+'S#71KMP) M+A8JZ$8WU%Z6-S*4E4N.=Z8?.W= MS?C!;ZB]TI730D1;#JO@*$ZPR3T :Q&CIOHDA^?L%#,-2,O005.3<'PQG-S< M=%YV[95I='Z@NY\[D#?V%3I M]N.>SSJGT;81' 42:CVV=GP^0!-[$'_E1H, MGY^-7J^WV\_5.V.6%&*DIHLN-\-5R*688(AF!7MZD ['Q'H7PGHYELEU'CXG M8 2<#TAID%$8DEU]&]K[;>C+WS3N;D(#OAV0#HK$N3"<3327H"I 'F 8P:U/ M:G/X[?B7OC"+WXIR:ET@83IDRI6L'T>GZ)^4-IGN9A,0GOYZ"-O\\HZH]C]P M5.*T+CDDG&-" 64I-+\((L&8V]9S&>)@Q!9Z"9H/?<^@[RH."@!D/!QQ3+O ' M$(-1()]A$9S(29,8)_-L&.B:)YN6KZV/F\R3++E/#AH,$Z I"KH$]@V[#>A M=\,XG1XC.SBC[K28 %,7YIH9Y "DR]B)N%+D[%WCPY, WL$>5V5E%O /0'+\ MK:P!?I8879(_)C:@$? [.5!$,J5T!T[Q\ZG!0!* S9K^I*S*1%?Z1'AT*;,E MA;[BSKF5B>>91:_)"=#D#%!F-5_PDH'>>$$4(SHA^JI3&,N%SH*#;#K_W/J_LOP3IF&0,/7A0N;^3#+#[LPRY\JS+*UM(IID!A$5;H]EZYD MPF8DU'\$PNH*KT.[1!BS!O!^6\R]/I>;]K[X\8&0YP:#*"]L1G$!V!2FI(>"KT=ND]3H#O&72=H-&>WJ?7;'B/I(Y4XS5^)Y8[-G,JD(*1IK<3E_:CP&1PL9- M[$JZYK3Z\V.%!M=7-OVNVPLZ47L37A Y"R4-V4A<97,SK%:B(#W&?J[NJINF M#!+=H:%]MZ%"[7F?+7EB]V\,O$B C7(<)8/S.F3$H&HO;DY:VK^GW#48PX6M MU$I9>3.8"Y^ZH"?[D%L"1.[1NW%#]]1SCD+VVNYW\K8GO28.P8Y%"E2TH]42 MM-@8FL!0=)8@0A2/?/"2>APY84>MDZBMFFB]2R#2"#5<5.:?-#,::U>MY792T6TY N](3T- M:+:APE[8KX,K=[G\FUB'^[J##:3Y:V(%6K,MVS=[^62PTK]Y'7M'MDM'^5R+SA'&!W4VLZ2I@PE5.M2U$;?OB.%9W%2G131>!W&!7BVGO(:H- M(6K+3<1'&[J7& _8DO0]NT9@>+RH%D^@Y[P\$A0U,Q"H"^IBY_P*3I*6[!<3?K&%-RF[ON=%I-8_Q MD)M*5!0V>9K/5BU'MI)>:Q@@&.8@.E4?0#E0UK?#>;O\Q%ODWU:VO=J[T?? M!RM(J;]^Y+V-+6KWN46)3.J:E0%OHL[BP FR92',6OA98 MTDW*P%X1IP+EEH,ZY[7O4>87YHDU07^?_\6.(C8DX'MNE[E_W,FIYQ8!/6D? MD*YYM"7FM-N6U/4FAB<^//DL3+R7?@,N8$>XI@G1;:ITP#?DLZ$10DAJ MT"Q'6)/?^##>TY*T\G_6SC-LRLG91YN.42Q(KB$&.V!)AJ1\B)X@!ZL[>:=< MHN8/0'+P5G[1>?>F4&]E.1].JQ4-)1K/V"YKEZ)[6+-I"4V?T^LK3#9<6/HY M)2F]NUUN>7.DW0>YCN=*7VHM0%CD; M?A0KD@QGNC$9;SCA'.1FIUC?CQ+%1Z>#Z(+OIQE%_6K_N#X.NQ#"RX^2?TESC,7:,Q!C-T)RX3ND=RW+#.9)Q1O(84.>41= 1(<01 MK0GV2BKM6F#" 4B&._,!R4G KF?URW5O8P=1[ MD^E*"*K4YJL]V IP-"XR%Q_.\BLQX,EU39="2X8 !P*HG[SXN@G5EM>T[&L\ M$Q^RN?>.]L71_^'-7;.18!?N"0H3]ASK-0N7#S;K*L>5[8#PWH-]=_HM2U': M2U(7!8 70:)+9?4CZ*@[HU2TTYI6ZU&LAZ[>Z>ZV J;"YT[ M"8/H1L>F<:;"?B^$N65>$,,4I)UJ=K#QM5-H#_)$A+,V!6NE5PEVV<2^7PKS M_&9^<1MZ[C0_^'9$[1>%7=N]6/%M?_!S-&I[.SRQ7&FZ+8:<9&V\[H'-C<:K M\\52%KZS0 UUAM?AX-2R9E(B:6([#)II1VU;H;;M=BI_<0;$-AP,7ZA7_;<] M]:\WH\'%*7K> /-C-?S/T?!-Q+38I2<@H!DFI 4]&5-]Y0W5BTJ"CZ<@@*G# M)EFU2ZHF02\22E7-QWFJ0PNX(QN,\E MX[[-N'\7PL2ZG]*AQ M8OGVDSKS;E6N&%F7ZIQCOO[%NOW7[MG3M"]KU( $MJ^P0S_W+),J!+^@S=$[_M\*_V^WDS4V;!E%JO]B%$5\#?6XS17H)67;@$FDPO"T;CE-VN5= MHM.0P#%&RKW.?!^6?&EC\N%CW,EGOYQ@LZ!VS0HG8E-/^:"NA+,>6A.6OL<# M5UABN@OGC$I,&*/?4H[5G;?7Z$+A+HY_("<3@Z\=A_3FTPN.K.<9)8GX!Y%KC72!89A!TQA M@:%*/2D,$3'IS D:OU6WP=RZ,<[M.C88W5S&19$_O,$)^.E2^J%QKSB*-*[= M0=R]Q9EO=_#12ZF<:R+"8613.F'ZWB)81[F,Q,K5PFU"#"5HH]6!V 0M(-5YBM^>?7DF. ,RAZT/43 M;6ZPX\G5@3V731/>2^!;!JSWC'?A0_/I/'C[Z/ 4:9V!WIS97+_-4#)I! M%F\69;*Y![XKSZ>]Q0_]_3$T5C\Y>G#_Z-']!X$M8INMK:@GH(=NOQ#8O[-%+H$M(8;8IC M=8Z7RJ/&^%SC_C&"_0QW.']S)+]!\G3(_B^']'\MPO_C)XVL#+D4P7=.'>7=NNX3D_]!Y+AF]NQ.Z^Q2T P'; M! &C?&**JL:F&>IIH?6[.\%CMX@$[N:!W2H6:^DB8\=UX _>.+B(#'DSQ9/?E_4$L! A0#% @ IER459W61;V( M! FQ8 !0 ( ! &]N9F]L:6\M,C R,C$R,34N>'-D M4$L! A0#% @ IER45: * 9[< 0 E , !@ ( !N@0 M &]N9F]L:6\M,C R,C$R,35?8V%L+GAM;%!+ 0(4 Q0 ( *9&UL4$L! A0#% @ IER4 M5<*#$22B0 !@ ( !]0\ &]N9F]L:6\M,C R,C$R M,35?<')E+GAM;%!+ 0(4 Q0 ( *9